FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

409277002: Levobetaxolol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2464728013 Levobetaxolol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2471079013 Levobetaxolol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2477383012 L-betaxolol en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levobetaxolol (substance) Is a Betaxolol (substance) false Inferred relationship Some
Levobetaxolol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta-1 adrenergic receptor antagonist (disposition) true Inferred relationship Some
Levobetaxolol (substance) Is a Beta-1 adrenergic receptor antagonist true Inferred relationship Some
Levobetaxolol (substance) Is a Propanolamine (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing levobetaxolol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levobetaxolol (substance) Inferred relationship Some 1
Levobetaxolol hydrochloride 0.5% ophthalmic suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levobetaxolol (substance) Inferred relationship Some
Product containing levobetaxolol in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levobetaxolol (substance) Inferred relationship Some 1
Levobetaxolol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levobetaxolol (substance) Inferred relationship Some 1
Product containing only levobetaxolol in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Levobetaxolol (substance) Inferred relationship Some 1
Levobetaxolol 5 mg/mL eye suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levobetaxolol (substance) Inferred relationship Some 1
Levobetaxolol 5 mg/mL eye suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Levobetaxolol (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start